Tuesday, 4 April, 2023 - 11:59
US investor backs WA manufacturing
Five months after striking a deal to buy Pfizer’s WA manufacturing operation, Bridgewest Group has completed the purchase and outlined plans to add to its 400 local staff.
Bridgewest Perth Pharma, a subsidiary of US investment company Bridgewest Group, was established in early 2023 as the group continues its expansion and investments in Western Australia with the recent purchase of the drug manufacturing facility of Pfizer (Perth), since renamed NovaCina.
![]() |
NEWS: Tagged in Ex-Pfizer site gets $2m govt cash injection | 14 Nov 2023 |
![]() |
NEWS: Tagged in Foreign buyers seize local opportunities | 02 May 2023 |
![]() |
NEWS: Tagged in US investor backs WA manufacturing | 04 Apr 2023 |
![]() |
NEW ROLE: Ian Wisenberg, Operating Partner | 04 Apr 2023 |
![]() |
NEW ROLE: Marc Rivers, President, Chief Financial Officer | 04 Apr 2023 |